SLC2A1 and neoplasm: Herein, we used GLUT1-specific ligands and GSH-sensitive linkers to construct a new PAMAM nanoconjugate to exploit the properties of these various motifs to enhance tumor cell targeting and tumor cell microenvironment-sensitive drug release with the aim of improving anticancer efficacy and reducing the systemic toxicity commonly accompanying chemotherapeutics.